ストックスクリーナーアプリを入手
0.45
4.13%
-0.0194
前日終値:
$0.4694
開ける：
$0.4771
24時間の取引高:
522.82K
Relative Volume:
0.57
時価総額：
$23.75M
収益：
-
当期純損益:
$-24.08M
株価収益率:
-0.525
EPS:
-0.8572
ネットキャッシュフロー:
$-14.75M
1週間 パフォーマンス:
-4.66%
1か月 パフォーマンス:
-24.91%
6か月 パフォーマンス:
-54.82%
1年 パフォーマンス:
-77.27%
1日の値動き範囲:
$0.45
$0.49
1週間の範囲:
$0.4351
$0.49
52週間の値動き範囲:
$0.3622
$2.10
Iterum Therapeutics Plc Stock (ITRM) Company Profile
ITRM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.45 | 24.78M | 0 | -24.08M | -14.75M | -0.8572 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-28 | アップグレード | Gabelli & Co | Sell → Hold |
| 2021-03-15 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | ダウングレード | Gabelli & Co | Buy → Sell |
| 2019-12-11 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Iterum Therapeutics Plc (ITRM) 最新ニュース
Iterum Therapeutics plc Stock Analysis and ForecastEarnings Forecast Updates & Fast Profit Stock Ideas - earlytimes.in
Iterum Therapeutics Faces Nasdaq Listing Compliance Challenge - TipRanks
Iterum Therapeutics receives Nasdaq notice on listing compliance - Investing.com
Iterum Therapeutics Plc (ITRM) can make a big difference with a little luck - setenews.com
Iterum Therapeutics expands reimbursement coverage for ORLYNVAH By Investing.com - Investing.com Nigeria
Iterum Therapeutics expands reimbursement coverage for ORLYNVAH - Investing.com
ITRM Expands ORLYNVAH Access and Secures Key Medicare Part D Agr - GuruFocus
Iterum Therapeutics provides business update - marketscreener.com
Iterum Therapeutics Provides Business Update - The Manila Times
Iterum Therapeutics (Nasdaq: ITRM) inks Medicare Part D deal, EU patent to 2039 - Stock Titan
Iterum Therapeutics (ITRM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Taking on analysts’ expectations and winning: Iterum Therapeutics Plc (ITRM) - setenews.com
Iterum Therapeutics Plc (ITRM) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Iterum’s antibiotic ORLYNVAH now available through McKesson By Investing.com - Investing.com Nigeria
Iterum’s antibiotic ORLYNVAH now available through McKesson - Investing.com
Iterum Therapeutics (ITRM) Expands Product Availability and FDA Clearance - GuruFocus
Iterum (NASDAQ: ITRM) Adds McKesson for ORLYNVAH as Sulopenem Disc Gains FDA 510(k) - Stock Titan
Q3 2025 Iterum Therapeutics PLC Earnings Call Transcript - GuruFocus
Is Iterum Therapeutics plc stock attractive after correctionPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Why retail investors favor Iterum Therapeutics plc stockJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Can Iterum Therapeutics plc stock maintain operating marginsJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Iterum Therapeutics director Dunne buys $2,191 in shares By Investing.com - Investing.com Nigeria
Dir Dunne Buys 6,000 ($2.2K) Of Iterum Therapeutics PLC [ITRM] - TradingView
[Form 4] Iterum Therapeutics plc Insider Trading Activity - Stock Titan
Can Iterum Therapeutics plc stock resist market sell offs2025 Big Picture & Fast Gain Swing Alerts - newser.com
Why Iterum Therapeutics plc stock appeals to analysts2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Combining machine learning predictions for Iterum Therapeutics plc2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Published on: 2025-11-19 01:58:59 - newser.com
Is Iterum Therapeutics plc stock attractive for long term wealth buildingQuarterly Market Review & Risk Managed Investment Strategies - newser.com
Using portfolio simulators with Iterum Therapeutics plc includedMarket Trend Report & Reliable Entry Point Alerts - newser.com
Iterum Therapeutics Plc (ITRM) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):